Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

Palifermin, a recombinant human keratinocyte growth factor, is commonly given to prevent mucositis following autologous transplantation. In the allogeneic hematopoietic stem cell transplant (allo-HSCT) setting, safety and efficacy data are limited. We performed a retrospective study in 251 patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Goldberg, Jenna D., Zheng, Junting, Castro-Malaspina, Hugo, Jakubowski, Ann A., Heller, Glenn, van den Brink, Marcel R.M., Perales, Miguel-Angel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054935/
https://ncbi.nlm.nih.gov/pubmed/22750997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2012.115
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller